Cardiff Oncology
CRDF
CRDF
77 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 6 closing their positions.
Holders
77
Holders Change
+22
Holders Change %
+40%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
17
Reduced
10
Closed
6
Calls
$4.67M
Puts
$325K
Net Calls
+$4.34M
Net Calls Change
+$4.33M
Top Buyers
1 |
1
Millennium Management
New York
|
$3.65M |
2 |
![]()
2
Marshall Wace
London,
United Kingdom
|
$2.32M |
3 |
3
Goldman Sachs
New York
|
$1.53M |
4 |
4
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$1.35M |
5 |
BC
5
BIT Capital
Berlin,
Germany
|
$1.26M |
Top Sellers
1 |
1
BlackRock
New York
|
$3.62M |
2 |
2
Renaissance Technologies
New York
|
$460K |
3 |
EP
3
Elkhorn Partners
Omaha,
Nebraska
|
$208K |
4 |
4
Two Sigma Advisers
New York
|
$116K |
5 |
XT
5
XTX Topco
George Town,
Cayman Islands
|
$0 |